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Background: This observational study documented heart rate over the entire course of electrically induced seizures
and aimed to evaluate the effects of stimulus electrode placement, patients' age, stimulus dose, and additional
predictors.
Method: In 119 consecutive patients with 64 right unilateral (RUL) and 55 bifrontal (BF) electroconvulsive
treatments, heart rate graphs based on beat-to-beat measurements were plotted up to durations of 130 s.
Results: In RUL stimulation, the initial drop in heart rate lasted for 12.5 ± 2.6 s (mean ± standard deviation). This
depended on stimulus train duration, age, and baseline heart rate. In seizures induced with BF electrode placement,
a sympathetic response was observed within the first few seconds of the stimulation phase (median 3.5 s). This was
also the case with subconvulsive stimulations. The mean peak heart rate in all 119 treatments amounted to 135 ±
20 bpm and depended on baseline heart rate and seizure duration; electrode placement, charge dose, and age
were insignificant in regression analysis. A marked decline in heart rate in connection with seizure cessation
occurred in 71% of treatments.
Conclusions: A significant independent effect of stimulus electrode positioning on cardiac action was evident only
in the initial phase of the seizures. Electrical stimulation rather than the seizure causes the initial heart rate increase
in BF treatments. The data reveal no rationale for setting the stimulus doses as a function of intraictal peak heart
rates (‘benchmark method’). The marked decline in heart rate at the end of most seizures is probably mediated by a
baroreceptor reflex.
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Cardiac action in electrically induced seizures follows a
characteristic phase-dependent course with rapid changes
[1]. In cases of unilateral or bitemporal electrode position-
ing, the administration of electrical stimuli is accompanied
by temporary asystole. The succeeding clonic phase of the
seizure is marked by tachycardia, arrhythmia, and hyper-
tension. Finally, the cessation of clonic movements some-
times coincides with another slowing of the heart rate
(HR) [2,3] whereas blood pressure continues to be ele-
vated for a few minutes longer [4].
The measurement of pulse rate and blood pressure once
a minute appears to be inadequate for investigating such
rapidly changing cardiac action. Besides, automated non-Correspondence: JosefNagler@gmx.de
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reproduction in any medium, provided the orinvasive blood pressure monitoring takes some time, often
more than 30 s, and cardiac action may not remain con-
stant during this period. In view of the rapid changes that
take place, precise statements regarding intraictal blood
pressure values require arterial catheterization [3] or a
special beat-to-beat monitoring device [5]. The accurate
measurement of heart rate is, in comparison, easy. Re-
cording of electrocardiogram (ECG) and pulse oximeter
curves is appropriate and well established in the setting of
anesthesia and convulsive therapy. Despite that easy acces-
sibility, studies on a beat-to-beat basis have rarely been
conducted, and their results are conflicting with regard to
the effects of age and stimulus dose.
Huang et al. [6] investigated the magnitude of cardio-
vascular changes in 13 consecutive patients. The max-
imal heart rate during the first treatment session had a
mean of 143 ± 25 beats per minute (bpm). It fellhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tween energy used and hemodynamic response. Swartz
and Shen [7] reported on a large non-consecutive
sample of 177 patients. The majority had left-anterior
right-temporal electrode placement, and 40 patients re-
ceived bifrontotemporal placement. Regression analysis
showed a small but significant decline of peak HR with
age. After separating the data points into two clusters,
the authors stated a desirable peak HR of 140 to 180
bpm, regardless of age.
In another paper [8], Swartz reported on heart rate re-
sponses following stimulation with half-age dose and
age-based dose. Electrode placement was in the left-
anterior right-temporal position. This study comprised
24 consecutive patients. It included five patients with ab-
sent or inadequate seizures in the group with half-age
dosing. Their peak heart rates were evidently lower than
during a fully developed seizure. By retaining four of
these patients in his data analyses, the author was able
to demonstrate significantly different heart rates between
the dosing regimes. A one-tailed t test after removal of
these subjects resulted in p = 0.044, so an ordinary two-
tailed t test would have shown no impact of the stimulus
dose on the peak heart rates in regular seizures.
The following observational study describes the car-
diac action in the course of 119 seizures induced by
right unilateral (RUL) or bifrontal (BF) stimulation. In
the same patient sample, a previous analysis of vagal ac-
tivation during the stimulation period [9] revealed a
mean asystole duration of 5.64 ± 2.88 s in RUL electro-
convulsive therapy (ECT). The application of electrical
pulses via BF electrodes was not associated with cardiac
pauses. In the present study, we evaluated whether the
subsequent intraictal cardiac action was different be-
tween RUL and BF ECT. The data pool was also suitable
for re-assessing the impact of age and stimulus dose on
heart rate.
Methods
Data were collected prospectively from all patients
undergoing electroconvulsive therapy in two hospitals
between October 2008 and June 2010. A total of 119 pa-
tients received treatment series with either RUL (n = 64)
or BF (n = 55) stimulation. Both clinics made use of a
Thymatron II device (Somatics Inc., Lake Bluff, IL, USA)
which provided a maximum charge of 1,008 mC with
current held constant at 0.9 A. For RUL stimulation, an
adhesive electrode was affixed to the right temple, and
the second electrode (mounted on a handle) was placed
adjacent to the vertex. For BF stimulation, two adhesive
electrodes were applied above the lateral halves of the
eyebrows, the alignment commonly being vertical. The
distance between their midpoints varied from 8.4 to 12
cm and averaged 10.3 ± 0.7 cm. The selection of theelectrode placement and the setting of the stimulus dose
were at the discretion of the attending psychiatrists.
Concomitant medications remained unchanged with the
exception of the dose before anesthesia. Further details
on treatment procedures and patient characteristics have
been described previously [9].
Anesthesia started with the IV administration of 0.25
mg atropine. Sleep was induced with etomidate, 0.2 mg/
kg, followed by succinylcholine at a dose of 100 mg in
the first session. No additional drugs were administered
in the routine procedure, except for propofol to termin-
ate seizures lasting longer than 80 s. All patients were
ventilated using a face mask, so that an oxygen satur-
ation of 100% and an end-tidal pCO2 ≤ 35 mmHg were
attained before stimulation. Anesthesia monitoring com-
prised ECG, pulse oximetry, capnometry, and non-
invasive blood pressure. During the actual convulsive
treatments, data were also recorded on paper printouts.
The same anesthetist was engaged in both clinics
throughout the study period.
Measurements and statistics
All R-R intervals in the ECG printout were measured
manually with a ruler and transformed into seconds.
Their cumulative sum forms the horizontal time axis for
the heart rate graphs shown in Figure 1. The heart rate
depiction on the vertical axis is based on the single R-R
intervals. The pulse oximeter curve served as a substi-
tute in case of impaired ECG recordings during the
stimulation phase. To keep the effort within limits, the
evaluation covered a maximum period of 130 s (includ-
ing stimulation) and was confined to the first treatment
session of each patient.
If the first treatment in an individual series could not
be evaluated, the subsequent treatment was analyzed. As
seizure durations commonly decrease during a treatment
series, that subsequent seizure was expected to be
shorter than the actual first one of the series. The
resulting bias was determined by re-analyzing the sam-
ple without those patients.
To characterize the heart rate graph, a total of ten out-
come variables were defined. The maximum heart rate
in the course of the seizure (peak HR) was calculated
from the shortest R-R interval in the ECG record; ec-
topic beats were excluded. Further outcomes were the
time from the onset of stimulation until the heart rate
rose above baseline level (Trise) and the time to peak
heart rate (Tmax). Tachycardia duration was assessed in
two ways: (1) the time period from the end of stimula-
tion until the heart rate fell to its baseline level again
(Tbase) and (2) the time to the center of the sharpest
heart rate decline within a 5-s period (Tdec) if a pro-
nounced decline was present. With the exception of
Trise, time (s) was always measured from the end of
Figure 1 Heart rate curves during electroconvulsive therapy. Horizontal gray lines, baseline heart rate; dotted vertical lines, end of
stimulation; broken vertical lines, end of motor seizure. (A) 39-year-old patient; RUL treatment, 151 mC; stimulus duration, 5.6 s. Baseline HR, 83
bpm; peak HR, 163 bpm; Trise, 9.3 s; Tmax, 19.2 s; Tbase, 54.0 s; Tdec, 58.5 s; motor seizure duration, 48 s. Gradual decline in heart rate at 25 s
indicating either mitigation of sympathetic impact or activation of parasympathetic forces during the seizure and a second decline following the
convulsive period. (B) 68-year-old patient; RUL stimulation, 195 mC, 7.5 s. Heart rate changed moderately from 77 to 107 bpm, and an abrupt
decline at the end of the seizure was absent. Medical evaluation revealed an impaired atrioventricular conduction combined with a bundle
branch block. (C) 43-year-old patient; RUL stimulation, 203 mC, 7.5 s. Asystole of 10.9 s duration; Trise, 13.9 s; motor seizure duration, 44 s. The
electrode placement was switched to BF position in this patient to prevent cardiac standstill during stimulation. Doses and treatment technique
remained otherwise unchanged (D). Trise, 2.9 s; motor seizure duration, 40 s; EEG seizure duration, 54 s. The post-ictal heart rate slowdown
proceeded to an asystole of 6.2 s duration. Medical evaluation was unremarkable, and pharmacotherapy consisted of citalopram. (E) 76-year-old
patient; BF treatment, 301 mC, 6.7 s. Trise, 2.6 s. The seizure end at 48 s was accompanied by a steep decline; the succeeding period of vagal
dominance was marked by arrhythmia.
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end of the seizure was calculated by HR at the end of
the seizure minus HR 20 s later. Final HR denoted the
heart rate before transfer to the post-anesthesia care
unit. Motor seizure duration was determined in
the right foot, which had been cuffed prior to the injec-
tion of succinylcholine. Electroencephalogram (EEG)
seizure duration was taken into account only if a flatline
was visible within 2 s after unequivocal seizure signs, in
accordance with a suppression index >90%. The term
seizure duration refers to motor seizure duration unless
otherwise stated.This was an observational study, and as in all such in-
vestigations, bias could be introduced by imbalances in
baseline characteristics. Bivariate comparisons were,
therefore, considered less conclusive and were reported
only for descriptive reasons. The independent effects of
age, charge dose, and electrode positioning (RUL versus
BF) on outcomes of interest were assessed in multiple
regression analysis. If clinical experience or previous in-
vestigations suggested further predictors, they were
added in the process of model building. SPSS 16.0 was
used for the calculations, and all significance tests were
two-sided. A total of eight regression analyses were
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of significance for the regression coefficients was adjusted
to p = 0.01. Because the preceding bivariate correlations
were considered to be descriptive, no adjustments were
made for multiple comparisons in these analyses. The cor-
responding p values should be interpreted accordingly.
Results
Upon arrival in the ECT unit, the patients, still aware
and oriented, had a mean heart rate of 82 ± 14 bpm and
a mean blood pressure of 136 ± 21 / 74 ± 11 mmHg.
The mean heart rate in anesthetized patients immedi-
ately before administration of the electrical stimuli was
90 ± 18 bpm. Automated blood pressure was monitored
once a minute; however, owing to divergent measuring
times, no clear assignments to seizure time points could
be established. The diastolic level in definite intraictal
measurements regularly exceeded 100 mmHg. When the
patients were transferred to the post-anesthesia care
unit, their mean heart rate was again 81 ± 15 bpm, and
the average blood pressure was 130 ± 22 / 72 ± 15
mmHg.
Table 1 shows the baseline characteristics of the pa-
tients according to electrode positioning (RUL versus
BF). The attending psychiatrists preferred bifrontal elec-
trode placement in the elderly and stimulus doses that
increased with age. Thus, age and charge dose were un-
evenly distributed among the groups. However, given the
paucity of data in this field, all outcome variables, separ-
ately for RUL and BF treatments, are listed in Table 2 as
raw data, with significance tests unadjusted for covari-
ates. The independent effects of the predictors, corrected
for baseline imbalances, were subsequently ascertained
by multiple regression analysis. The results are
reported below in the order of the outcome variables.
The mean peak HR in all treatments was 135 ± 20
bpm. Bivariate analyses showed a moderate correlation
with baseline HR (r = 0.358, p = 0.000) and another one
with the patients' age (r = −0.190, p = 0.041). Charge
dose had no effect on the peak HR (r = −0.135, p =
0.149). The same applied to the positioning of the stimu-
lus electrodes (Table 2, p = 0.296). The time taken to
reach the peak HR (Tmax) overlapped the seizureTable 1 Baseline characteristics in right unilateral and bifront
RUL ECT (n = 64)
Mean ± SD Median (range)
Age (yr) 53 ± 12 52 (29–79)
First HR (bpm) 81 ± 13 80 (56–123)
Baseline HR (bpm) 90 ± 17 88 (55–127)
Charge dose (mC) 222 ± 96 197 (88–605)
SD, standard deviation; range, minimum-maximum range; First HR (bpm), heart rate
(beats per minute) immediately before stimulation; at test; bMann–Whitney U test.durations (Table 2), and an association between tachy-
cardia and seizure duration was common, leading to
the assumption of lower peak HRs in short seizures.
There was in fact some association between motor seiz-
ure duration and peak HR (r = 0.195, p = 0.038). The
multiple regression analysis confirmed the baseline HR
(B = 0.456, p = 0.000) and seizure duration (B = 0.396,
p = 0.005) as independent predictors. A higher baseline
HR of 10 bpm was associated with a higher peak HR of
5 bpm and reducing seizure durations by 10 s brought
down peak HRs by 4 bpm on average.
The time until the HR started rising above baseline
(Trise) was considerably longer in RUL ECT than in BF
stimulation and showed a bimodal distribution with a
median of 3.5 s in BF electrode placement and 12.5 s in
RUL positioning. As evident from Table 3, the 9 s earlier
increase in heart rate during BF stimulation was inde-
pendent of age, charge dose, and baseline HR.
The onset of tachycardia was traceable in half of the
BF treatments as early as 3.5 s after initiation of the elec-
trical pulses. At the end of the stimulation period, which
lasted for 7.2 s on average, a higher heart rate was
present in 43 of the 55 patients. None of the predictors
listed in Table 3 had an influence on Trise in the BF sub-
group after an outlier (baseline HR 139 bpm, Trise = 14.6 s)
was removed.
In RUL treatments, bivariate analyses revealed correla-
tions of Trise with age (r = 0.400, p = 0.001), stimulus
duration (r = 0.574, p = 0.000), and baseline HR (r =
0.407, p = 0.001). The predictors remained significant in
regression analysis. It took longer for older patients to
exceed their baseline level, and it took more time to
exceed a higher baseline. Clinical relevance can be at-
tributed to the high coefficient of the stimulus dur-
ation (B = 1.27, p = 0.000). Extending the duration
by 1 s prolonged the corresponding parasympathetic
phase by 1.27 s.
The time interval between stimulation and peak HR
(Tmax) did not differ in RUL and BF ECT. Regression ana-
lysis established an effect of age (B = 0.356, p = 0.000) and
frequency (B = −0.201, p = 0.006). The calculation, how-
ever, was flawed by heteroscedasticity and its predictive
value was only 12%.al treatments
BF ECT (n = 55) p value
Mean ± SD Median (range)
71 ± 7 71 (43–86) 0.000a
83 ± 15 83 (50–124) 0.490a
89 ± 18 88 (60–139) 0.677a
350 ± 174 323 (151–1014) 0.000b
(beats per minute) upon arrival in the ECT unit; Baseline HR (bpm), heart rate
Table 2 Outcome variables in right unilateral and bifrontal treatments
RUL ECT (n = 64) BF ECT (n = 55) p value
Mean ± SD Median (range) Mean ± SD Median (range)
Peak HR (bpm) 137 ± 20 136 (88–187) 133 ± 20 134 (91–167) 0.296a
Trise (s) 12.5 ± 2.6 12.5 (6.3–17.8) 4.5 ± 3.1 3.5 (0.7–14.6) 0.000
b
Tmax (s) 20.2 ± 8.8 19.1 (9.1–61.2) 21.3 ± 10.4 19.4 (0.0–60.1) 0.535
b
Tbase (s) 55.8 ± 21.7 54.0 (13.3–107.2) 67.0 ± 25.9 62.1 (21.2–117.7) 0.026
a
Tdec (s) 54.3 ± 21.9 54.7 (13.3–107.6) 62.1 ± 18.7 61.0 (22.1–95.8) 0.063
b
HR at seizure end (bpm) 114 ± 27 115 (45–163) 119 ± 23 121 (50–163) 0.271a
HR 20 s after seizure (bpm) 78 ± 27 71 (28–156) 94 ± 22 96 (50–139) 0.002b
Final HR (bpm) 81 ± 14 81 (50–115) 82 ± 18 80 (49–125) 0.742a
Seizure duration (s) 45 ± 12 45 (13–78) 51 ± 13 51 (28–85) 0.013a
EEG seizure duration (s) 74 ± 26 70 (19–116) 55 ± 15 54 (33–83) 0.057a
SD, standard deviation; range, minimum-maximum range; HR (bpm), heart rate (beats per minute). Time (s) is always measured from the end of stimulation with
the exception of Trise.
Trise, time from the onset of stimulation until the heart rate rises above baseline level; Tmax, time to peak heart rate; Tbase, time until the heart rate falls to baseline
level; Tdec, time to the steepest heart rate decline during and after the seizure; Final HR, heart rate before transfer to the post-anesthesia care unit.
at test;
bMann–Whitney U test.
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below baseline in 93 patients (78%). Short self-limiting
asystole events could be seen in RUL as well as in BF
treatments. The longest pause in the 119 ECGs of this
sample lasted for 4.1 s. In 26 patients, the heart rate
remained above baseline or could not be determined
because of frequent extrasystoles. The time at which
the heart rate fell to its baseline level (Tbase) was often
associated with the termination of motor convulsions
(r = 0.620, p = 0.000). There were additional correlations
with baseline HR (r = −0.217, p = 0.036) and peak HR
(r = 0.276, p = 0.007), but they were trivial if Tbase was
chosen as the outcome variable.
Taking the point of greatest heart rate deceleration
(Tdec) as the end point of tachycardia resulted in a simi-
larly high correlation with the convulsive period (r =
0.692, p = 0.000). As shown in Table 3, there were noTable 3 Regressions of four outcome variables (row 1) on ass
Peak HR
Constant 91.541 (15.808)* 1.52
Age (yr) −0.193 (0.176) 0.08
Charge dose (mC) −0.015 (0.013) 0.00
Positioninga 0.402 (4.810) −9.63
Baseline HR (bpm) 0.456 (0.101)* 0.06
Stimulus duration (s)




Trise, time from the onset of stimulation until the heart rate rises above baseline lev
steepest heart rate decline during and after the seizure. Cell values in predictor row
aRelative to RUL positioning.confounding variables. The effects of baseline and peak
HR were likewise negligible. A formal correlation existed
with EEG seizure duration (r = 0.774, p = 0.000). In
most cases, however, Tdec preceded the EEG end point,
so the latter variable did not seem to be a suitable pre-
dictor for the former. An abrupt EEG end point was
only recorded in 25 RUL and 8 BF treatments.
The speed of decline in heart rate at the end of the
seizure could be assessed in 94 patients. In the 20 s fol-
lowing the termination of seizure activity, the heart rate
fell by 30 ± 20 bpm with a median of 25 and a range of
−3 to 89 bpm. The decline was faster in the case of
higher peak HRs (B = 0.384, p = 0.000); it was attenu-
ated in lengthy seizures (B = −0.434, p = 0.003) and in
older patients (B = −0.315, p = 0.027).
No conclusions could be drawn regarding the determi-
nants of the seizure duration. There were only weakumed predictors (column 1)
Trise Trise RUL Tdec
5 (1.771) −4.844 (2.250) 6.042 (11.994)
4 (0.023)* 0.075 (0.022)* 0.039 (0.178)
2 (0.002) −0.003 (0.003) −0.014 (0.013)
0 (0.621)* 2.602 (5.376)






el; Trise RUL, Trise in patients with right unilateral stimulation; Tdec, time to the
s are B coefficients with standard errors in parentheses; *p values < 0.01.
Figure 2 Peak heart rate as a function of baseline heart rate
and charge dose. In 32 patients, the initial charge dose (level 1)
was doubled (level 2) over the course of the treatment series. The
figure indicates positive correlations between baseline heart rates
and peak heart rates at both levels and the absence of higher peak
heart rates when charge doses were doubled. Mean peak heart rate
at level 1, 130 ± 19 bpm; mean peak heart rate at level 2, 123 ±
20 bpm.
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stimulation (Table 2) and, in the RUL subgroup, a longer
convulsive period in younger patients and those with a
lower charge dose. A valid regression equation could not
be established. The records of the first treatment were
incomplete in 11 patients (9%), and we thus evaluated a
subsequent session instead. This could have biased the
calculations referring to seizure durations. However,
when excluding these patients from the analysis, mean
seizure durations proved to be only 1 s longer in RUL
and BF treatments, and the pattern of significance in the
equations of Table 3 remained unchanged.
Discussion
Peak heart rate
In our sample of 119 patients, peak heart rates during
electroconvulsive therapy ranged from 88 to 187 bpm
and averaged 135 ± 20 bpm. Only 50 patients exceeded
a heart rate of 140 bpm during seizure. The correspond-
ing mean in the study of Swartz and Shen [7] was 154 ±
22 bpm for men and 160 ± 17 bpm for women. The
higher numbers might be due to their selection of the
peak heart rate of each patient from all treatments.
Huang et al. and the present study focused on the first
session only. Furthermore, heart rate numbers on a
digital display, as used by Swartz and Shen, might in-
clude ectopic beats and additional interference.
In line with Huang et al. [6] and Swartz and Shen [7],
we found an effect of age on peak HR in bivariate ana-
lysis. However, it was small and lost its significance
when baseline HR and seizure duration were taken into
account.
We could not reproduce the ‘general absence of cor-
relation between peak and baseline HRs,’ as stated by
Swartz in 1999 [10]. In our sample of 119 patients, a
correlation was present in RUL as well as in BF ECT,
and the impact of baseline HR on peak HR remained
significant after adjustment for covariates (Table 3). A
positive correlation was equally evident in a second sam-
ple of 32 treatments in which the charge doses had been
doubled (r = 0.515, p = 0.003, Figure 2). The lack of sig-
nificance in the study of Swartz is probably due to the
small number of patients (n = 24).
This small sample size also formed the statistical basis
for the ‘Benchmark Method’ [11], in which the stimulus
dose is to be set according to the peak HR obtained in
previous seizures. The method requires (1) a causal rela-
tionship between charge dose and peak HR and (2) an-
other linkage of higher peak HRs to greater treatment
efficiency. Our study found no evidence of a positive
correlation between stimulus dose and peak HR in RUL
or BF ECT. The coefficient was also insignificant in re-
gression analysis (B = −0.015, p = 0.250). There was no
evidence that the administration of higher stimulusdoses in the first treatment of a series caused higher
heart rates.
We therefore investigated the relationship between
stimulus dose and heart rate in an additional
intraindividual comparison. This involved all patients
where the initial stimulus doses had been doubled dur-
ing their treatment series (n RUL = 16, n BF = 16).
Subconvulsive stimuli were not taken into account. Al-
though the mean charge dose in these 32 patients had
been doubled from 253 ± 106 mC to 507 ± 211 mC,
there was no corresponding increase in the peak HRs.
On the contrary, their mean fell from 130 ± 19 bpm to
123 ± 20 bpm (p = 0.003, t test). This decrease is not
surprising given that the baseline HRs fell from 90 ±
18 bpm in the first treatments to 83 ± 16 bpm in the
subsequent treatments. Likewise, seizure durations fell
from 45 ± 12 to 34 ± 11 seconds. Doubling the stimu-
lus dose in the course of a treatment series seems to be
a futile attempt to achieve higher peak HRs (Figure 2).
Increase and decrease of heart rate
Heart rate during the stimulation period of ECT is gen-
erally expected to fall [12,13]. This study is the first to
demonstrate an increase in heart rate during the
bifrontal application of electrical stimuli with an inter-
electrode distance ≤ 8 cm. The impact of electrode
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peatedly [9,12]; hence, the electrode distance seems
crucial to the new finding. A possible physiological
mechanism underlying this heart rate increase is
discussed below.
In the present study, the time from the onset of stimu-
lation until the heart rate started rising above baseline
(Trise) served as an outcome variable. In a previous ana-
lysis of the same patient sample [9], we had chosen the
longest interval between two heartbeats to quantify car-
diac action during the stimulation phase. This cardiac
pause length had varied greatly in the RUL group (1.21–
11.20 s), and it had been impossible to identify any pre-
dictors. Taking ‘Trise’ as an outcome variable instead of
the ‘stimulation interval’ yielded markedly better results.
Age, baseline HR, and stimulus duration turned out to
be significant predictors in the RUL group, explaining
more than 50% of the variation, as shown in Table 3.
The time span from the onset of stimulation until the
heart rate starts to rise above baseline evidently reflects
the interplay of parasympathetic and sympathetic forces
during stimulation more precisely than the longest inter-
val between two heartbeats.
The effect of stimulus duration on Trise in the RUL
group is in line with recently published findings. Stewart
et al. [12] found a greater heart rate deceleration and
more asystole events in longer stimulus trains, and
Coughlin et al. [13] observed longer cardiac pauses when
the stimulus durations were doubled from 2 to 4 s. Dif-
ferent outcome variables notwithstanding, all the studies
agree that bradycardia or asystole are prolonged in the
case of longer RUL stimulation.
Incidents of temporary asystole concomitant with the
end of seizure signs have been described repeatedly
[14-17]. In 1984, Larson et al. [2] assessed the utility ofFigure 3 Sympathetic surge during subconvulsive and convulsive bifr
patient. Stimulus electrodes had been placed at a distance of 6 cm, that is,
onset of tachycardia. The first stimulation (203 mC, 7.5 s, 30 Hz, 0.50 ms) w
stimulation (280 mC, 7.7 s, 40 Hz, 0.50 ms) led to a seizure of 60-s durationECT-induced tachycardia as a measure of seizure length.
They marked the sharp decline in heart rate as the end
point of intraictal tachycardia. The point at which the
heart rate graph crosses its baseline level again (Tbase)
can often be determined more simply. This point, how-
ever, is reached more rapidly in the case of a high base-
line or a low peak HR. Tdec is not affected and seems to
be more appropriate for marking the onset of the post-
ictal period of vagal dominance.
Possible physiological mechanisms
The parasympathetic surge during stimulation depended
on the positioning of the stimulus electrodes; it appeared
with the first cardiac action starting in the stimulation
period, and it was strongly linked to stimulus train dur-
ation. Bradycardia was also visible during irregular RUL
stimulations. In the case of an interrupted treatment, we
recorded a prompt heartbeat slowdown induced by no
more than 14 pulses of 0.5 ms each (frequency, 40 Hz;
train duration, 0.18 s). All these observations are explic-
able by assuming direct stimulation of the vagus nerve if
the electrical field is placed in its proximity.
The quick activation of the sympathetic nervous sys-
tem in the first half of the stimulation period was only
traceable in the ECG records of BF treatments. As
evident from its rapid onset, this tachycardia is neur-
ally mediated. Epinephrine from the adrenal glands
might contribute to cardiovascular action later on but
cannot play a part at an early stage. A valuable insight
into the physiological mechanisms was provided by
subconvulsive stimulations, i.e., stimulations followed by
neither motor nor EEG seizure signs. There were no
such cases within the RUL sample and six (11%) in the
BF group; all were successfully re-stimulated at higher
doses. Cardiac action was similar in subconvulsive andontal stimulation. The figure shows ECT no. 4 in a 66-year-old male
a distance of 10 cm between the midpoints. Arrows indicate the
as followed by neither motor nor EEG seizure signs. The subsequent
.
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cardioacceleration during application of the electrical
pulses. Subsequently, the heart rate fell below baseline
level in three patients within 4.2–17.8 s following comple-
tion of the subconvulsive stimuli. The onset of tachycardia
during BF stimulation can hence be attributed to the ap-
plication of electrical pulses rather than to the seizure it-
self (Figure 3). Bifrontal electrical stimulation can activate
the sympathetic nervous system for some seconds even in
cases of a subconvulsive charge dose.
At the end of the seizures, some heart rate graphs
gradually drifted towards baseline. In 78% of cases, how-
ever, they fell below that level and a steep, non-steady
decline was recorded in 71%. These time curves are indi-
cative of additional activation of the vagus nerve. Unlike
the vagal surge during stimulation, it did not depend on
electrode positioning. A potential mechanism is reflex
bradycardia. Neurally mediated sympathetic activity is
mainly based on norepinephrine. The IV infusion of this
neurotransmitter rapidly leads to vasoconstriction and
blood pressure elevation and is consistently followed by
bradycardia. In keeping with neural mediation, arterial
line recordings in ECT showed maximum systolic and
diastolic blood pressure levels within 7 s of the first
post-stimulus heartbeat [3]. The baroreceptor response
is to be expected as a result.Conclusions
In this study, stimulus electrode positioning had a
marked effect on cardiac action during electroconvulsive
therapy in the stimulation phase. We did not find an ef-
fect on heart rate during the subsequent convulsive
period. The influence of the patients' age on cardiac ac-
tion in ECT seemed to be only of minor importance:
bradycardia lasted longer during RUL stimulation; the
heart rate reached its maximum a little later and had a
tendency to decrease more gradually at the end of the
seizure. The common decline of autonomic nervous
system function in old age offers a simple explanation
for this blunted heart rate response. The stimulus dose
had no independent effect on heart rate, particularly
peak heart rate, in fully developed seizures. In conse-
quence, peak heart rate is an unsuitable parameter for
adjusting the stimulus dose.Abbreviations
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